首页> 外文期刊>Hormone and Metabolic Research >Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis
【24h】

Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis

机译:慢性肾衰竭患者亚甲状旁腺全切除术与全甲状旁腺切除术加自体移植治疗继发性甲状旁腺功能亢进的比较:荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

We conducted a meta-analysis of randomized and 2-arm prospective or retrospective studies that compared the efficacy of PTX and TPTX+AT in patients with medically uncontrollable secondary HPT due to chronic renal failure. Citations were identified in the Medline, Cochrane, EMBASE, and Google Scholar databases through April 2014. The primary outcome of interest was HPT recurrence rate, while secondary outcomes included changes in serum calcium (Ca++), parathyroid hormone (PTH), alkaline phosphatase (ALP), and phosphate (P) levels. Five studies were included in the present analysis. The NOS score of all the included studies was 7 or above, and heterogeneity among the studies was minimal for 3 of the 5 outcomes. The HPT recurrence rate was similar for patients who underwent SPTX vs. TPTX+AT [odds ratio (OR)=0.825; 95% confidence interval (CI)=0.368 to 1.846; p=0.639]. The changes in serum Ca++, PTH, ALP, and P were also similar between the 2 treatment groups (Ca++: Std diff in means=-0.166; 95% CI=-0.703 to 0.371; p=0.545; PTH: pooled diff in means=561.17; 95% CI=-174.30 to 1296.6; p=0.135; ALP: pooled diff in means=0.58; 95% CI=-70.07 to 71.24; p=0.987; P: pooled Std diff in means=0.26; 95% CI=-0.091 to 0.630; p=0.143). Our findings indicate that SPTX and TPTX+AT are equally successful in preventing recurrent HPT and improving secondary HPT. We therefore, conclude that the choice of procedure can be left to the surgeons.
机译:我们进行了一项随机和两臂前瞻性或回顾性研究的荟萃分析,比较了PTX和TPTX + AT在由于慢性肾功能衰竭导致医学上无法控制的继发性HPT患者中的疗效。直到2014年4月,在Medline,Cochrane,EMBASE和Google Scholar数据库中均发现了引文。主要关注的结果是HPT复发率,次要结果包括血清钙(Ca ++),甲状旁腺激素(PTH),碱性磷酸酶( ALP)和磷酸盐(P)含量。本分析包括五项研究。所有纳入研究的NOS得分均为7或以上,在5项结果中的3项中,研究之间的异质性最低。接受SPTX与TPTX + AT的患者的HPT复发率相似[赔率(OR)= 0.825; 95%置信区间(CI)= 0.368至1.846; p = 0.639]。在两个治疗组之间血清Ca ++,PTH,ALP和P的变化也相似(Ca ++:标准差均值= -0.166; 95%CI = -0.703至0.371; p = 0.545; PTH:平均均值合并差= 561.17; 95%CI = -174.30至1296.6; p = 0.135; ALP:均值合并差值= 0.58; 95%CI = -70.07至71.24; p = 0.987; P:均值合并标准差= 0.26; 95% CI = -0.091至0.630; p = 0.143)。我们的发现表明,SPTX和TPTX + AT在预防复发性HPT和改善继发性HPT方面同样成功。因此,我们得出结论,程序的选择可以留给外科医生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号